Ovulation Inhibition

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Ovulation Inhibition trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT07365904

Investigating Ovulation Inhibition for Use as a Contraceptive

A single-centre, open-label, randomised, phase II study on the maintenance of ovulation inhibition after intentional application errors during 84 days of treatm…

Germany60 participantsStarted 2025-12-22

Treatment: MR-130A-01 contraceptive transdermal patch, containing norelgestromin (NGMN)

All recent trials (23 shown)

CompletedPhase 2

NCT01586000

A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycl…

This clinical trial is an experimental research study using a potential new form of birth control. Clinical trials include people who volunteer to take part in…

United States197 participantsStarted 2012-03

Treatment: 10 µg/day E2 with NES 200® µg/day, 20 µg/day E2 with NES 200® µg/day

CompletedNot Applicable

NCT06396221

"Quick-starting" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestra…

The goal of this clinical trial is to learn if Estetrol/Drospirenone inhibit ovulation in quick-starting method. It will also learn about the safety of Estetrol…

Thailand36 participantsStarted 2024-05-01

Treatment: Estetrol 15 mg/Drospirenone 3 mg (24/4), Ethinylestradiol (EE) 20 mcg/Gestodene 75 mcg (21/7)

Ovulation Inhibition

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Investigating Ovulation Inhibition for Use as a Contraceptive

All recent trials (23 shown)

A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycl…

"Quick-starting" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestra…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Investigating Ovulation Inhibition for Use as a Contraceptive

All recent trials (23 shown)

A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycl…

"Quick-starting" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestra…

"Quick-starting" of a Quadriphasic Contraceptive Pills, 1 - 3 mg Estradiol Valerate/ 2 - 3 mg Dienogest VS 20 mcg Ethiny…

Can Ibuprofen Delay Ovulation in Natural Cycle-IVF?

US Ovulation Inhibition Study in Obese Women

Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control

Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal Contraception

Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg…

A Study to Evaluate the Effect of a Contraceptive Vaginal Ring Delivering Ulipristal Acetate Combined With a Single or R…

Human Ovarian Follicular Dynamics and Emergency Contraception

Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0m…

Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression

A Phase 2, Dose-finding, Cross-over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppr…

A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a P…

Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene

Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 T…

Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD)

Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Reg…

Bioequivalence Study: 3 mg Estradiol Valerate (EV) With and Without Levomefolate Calcium

Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition